News
-
-
COMMUNIQUÉ DE PRESSE
Kuros Biosciences Reports Results for First Half 2023
-
COMMUNIQUÉ DE PRESSE
Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
-
COMMUNIQUÉ DE PRESSE
Annual General Meeting of Kuros Biosciences approves all resolutions
-
COMMUNIQUÉ DE PRESSE
Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023
-
COMMUNIQUÉ DE PRESSE
Kuros Biosciences reports results for the full year 2022
-
-
COMMUNIQUÉ DE PRESSE
Kuros Biosciences Announces Changes to Executive Management Team